{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:58:54Z","timestamp":1793213934136,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hematologic malignancies (HMs) are a heterogeneous group of cancers that comprise diverse subgroups of neoplasms. So far, despite the major epidemiologic concerns about the quality of care, limited data are available for patients with HMs. Thus, we created a novel measure\u2014Quality of Care Index (QCI)\u2014to appraise the quality of care in different populations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The Global Burden of Disease data from 1990 to 2017 applied in our study. We performed a principal component analysis on several secondary indices from the major primary indices, including incidence, prevalence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years (DALYs) to create the QCI, which provides an overall score of 0\u2013100 of the quality of cancer care. We estimated the QCI for each age group on different scales and constructed the gender disparity ratio to evaluate the gender disparity of care in HMs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Globally, while the overall age-standardized incidence rate of HMs increased from 1990 to 2017, the age-standardized DALYs and death rates decreased during the same period. Across countries, in 2017, Iceland (100), New Zealand (100), Australia (99.9), and China (99.3) had the highest QCI scores for non-Hodgkin lymphoma, multiple myeloma, Hodgkin lymphoma, and leukemia. Conversely, Central African Republic (11.5 and 6.1), Eritrea (9.6), and Mongolia (5.4) had the lowest QCI scores for the mentioned malignancies respectively. Overall, the QCI score was positively associated with higher sociodemographic of nations, and was negatively associated with age advancing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The QCI provides a robust metric to evaluate the quality of care that empowers policymakers on their responsibility to allocate the resources effectively. We found that there is an association between development status and QCI and gender equity, indicating that instant policy attention is demanded to improve health-care access.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40164-021-00198-2","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T22:39:42Z","timestamp":1612823982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990\u20132017"],"prefix":"10.1186","volume":"10","author":[{"given":"Mohammad","family":"Keykhaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masood","family":"Masinaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmaeil","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Azadnajafabad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Saeedi Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazila","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Nasserinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Abbasi-Kangevari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Reza","family":"Malekpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed-Hadi","family":"Ghamari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Haghshenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Koliji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Kompani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8288-4046","authenticated-orcid":false,"given":"Farshad","family":"Farzadfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,8]]},"reference":[{"key":"198_CR1","doi-asserted-by":"crossref","unstructured":"GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859\u2013922.","DOI":"10.1016\/S0140-6736(18)32335-3"},{"key":"198_CR2","unstructured":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues: International Agency for Research on Cancer- World Health Organization. https:\/\/www.iarc.fr\/news-events\/who-classification-of-tumours-of-haematopoietic-and-lymphoid-tissues-2\/."},{"issue":"Suppl 1","key":"198_CR3","doi-asserted-by":"publisher","first-page":"i3","DOI":"10.1093\/annonc\/mdl443","volume":"18","author":"D Rodriguez-Abreu","year":"2007","unstructured":"Rodriguez-Abreu D, Bordoni A, Zucca E. Epidemiology of hematological malignancies. Ann Oncol. 2007;18(Suppl 1):i3\u20138.","journal-title":"Ann Oncol"},{"issue":"6","key":"198_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"198_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40164-020-00170-6","volume":"9","author":"Y Dong","year":"2020","unstructured":"Dong Y, Shi O, Zeng Q, Lu X, Wang W, Li Y, et al. Leukemia incidence trends at the global, regional, and national level between 1990 and 2017. Exp Hematol Oncol. 2020;9:14.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"198_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-019-0799-1","volume":"12","author":"L Zhou","year":"2019","unstructured":"Zhou L, Deng Y, Li N, Zheng Y, Tian T, Zhai Z, et al. Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study. J Hematol Oncol. 2019;12(1):107.","journal-title":"J Hematol Oncol"},{"issue":"17","key":"198_CR7","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1200\/JCO.2008.21.1680","volume":"27","author":"E Goss","year":"2009","unstructured":"Goss E, Lopez AM, Brown CL, Wollins DS, Brawley OW, Raghavan D. American society of clinical oncology policy statement: disparities in cancer care. J Clin Oncol. 2009;27(17):2881\u20135.","journal-title":"J Clin Oncol"},{"issue":"28","key":"198_CR8","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1200\/JCO.2011.35.8903","volume":"29","author":"B Moy","year":"2011","unstructured":"Moy B, Polite BN, Halpern MT, Stranne SK, Winer EP, Wollins DS, et al. American Society of Clinical Oncology policy statement: opportunities in the patient protection and affordable care act to reduce cancer care disparities. J Clin Oncol. 2011;29(28):3816\u201324.","journal-title":"J Clin Oncol"},{"key":"198_CR9","doi-asserted-by":"crossref","unstructured":"GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736\u201388.","DOI":"10.1016\/S0140-6736(18)32203-7"},{"key":"198_CR10","doi-asserted-by":"crossref","unstructured":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789\u2013858.","DOI":"10.1016\/S0140-6736(18)32279-7"},{"key":"198_CR11","unstructured":"GBD Compare: Institute for Metrics and Evaluation; [updated November 1, 2020. https:\/\/gbd2017.healthdata.org\/gbd-compare\/."},{"issue":"10062","key":"198_CR12","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","volume":"388","author":"GA Stevens","year":"2016","unstructured":"Stevens GA, Alkema L, Black RE, Boerma JT, Collins GS, Ezzati M, et al. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. Lancet. 2016;388(10062):e19\u201323.","journal-title":"Lancet"},{"issue":"11","key":"198_CR13","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1080\/07408170500232784","volume":"37","author":"AC Rencher","year":"2005","unstructured":"Rencher AC. A Review Of \u201cMethods of Multivariate Analysis, Second Edition.\u201d IIE Trans. 2005;37(11):1083\u20135.","journal-title":"IIE Trans"},{"key":"198_CR14","doi-asserted-by":"crossref","unstructured":"Mohammadi E, Ghasemi E, Moghaddam SS, Yoosefi M, Roshani S, Ahmadi N, et al. Quality of Care Index (QCI). protocolsio. 2020.","DOI":"10.17504\/protocols.io.bprjmm4n"},{"key":"198_CR15","doi-asserted-by":"publisher","first-page":"e2017006","DOI":"10.4178\/epih.e2017006","volume":"39","author":"E Choi","year":"2017","unstructured":"Choi E, Lee S, Nhung BC, Suh M, Park B, Jun JK, et al. Cancer mortality-to-incidence ratio as an indicator of cancer management outcomes in Organization for Economic Cooperation and Development countries. Epidemiol Health. 2017;39:e2017006.","journal-title":"Epidemiol Health"},{"key":"198_CR16","first-page":"12","volume":"15","author":"CY Huang","year":"2018","unstructured":"Huang CY, Au KK, Chen SL, Wang SC, Liao CY, Hsu HH, et al. Unfavorable mortality-to-incidence ratio of lung cancer is associated with health care disparity. Int J Environ Res Public Health. 2018;15:12.","journal-title":"Int J Environ Res Public Health."},{"key":"#cr-split#-198_CR17.1","unstructured":"Global Burden of Disease Study 2015 (GBD 2015) Socio-Demographic Index (SDI) 1980-2015: Institute for Health Metrics and Evaluation"},{"key":"#cr-split#-198_CR17.2","unstructured":"[updated November 1, 2020. http:\/\/ghdx.healthdata.org\/record\/ihme-data\/gbd-2015-socio-demographic-index-sdi-1980%E2%80%932015."},{"key":"198_CR18","unstructured":"The R Project for Statistical Computing: The R Foundation; [updated November 1, 2020. http:\/\/www.r-project.org\/, ."},{"key":"198_CR19","doi-asserted-by":"crossref","unstructured":"GBD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet. 2018;391(10136):2236\u201371.","DOI":"10.1016\/S0140-6736(18)30994-2"},{"issue":"4","key":"198_CR20","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1182\/blood-2017-02-734541","volume":"130","author":"J Taylor","year":"2017","unstructured":"Taylor J, Xiao W, Abdel-Wahab O. Diagnosis and classification of hematologic malignancies on the basis of genetics. Blood. 2017;130(4):410\u201323.","journal-title":"Blood"},{"issue":"10","key":"198_CR21","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1172\/JCI61188","volume":"122","author":"WM Kuehl","year":"2012","unstructured":"Kuehl WM, Bergsagel PL. Molecular pathogenesis of multiple myeloma and its premalignant precursor. J Clin Investig. 2012;122(10):3456\u201363.","journal-title":"J Clin Investig"},{"issue":"4","key":"198_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/2040620713498161","volume":"4","author":"E Stieglitz","year":"2013","unstructured":"Stieglitz E, Loh ML. Genetic predispositions to childhood leukemia. Ther Adv Hematol. 2013;4(4):270\u201390.","journal-title":"Ther Adv Hematol"},{"key":"198_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1259\/bjr.70.830.9135438","volume":"70","author":"R Doll","year":"1997","unstructured":"Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol. 1997;70:130\u20139.","journal-title":"Br J Radiol"},{"issue":"1","key":"198_CR24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13045-020-00908-z","volume":"13","author":"M Yi","year":"2020","unstructured":"Yi M, Li A, Zhou L, Chu Q, Song Y, Wu K. The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017. J Hematol Oncol. 2020;13(1):72.","journal-title":"J Hematol Oncol"},{"issue":"22","key":"198_CR25","first-page":"22869","volume":"12","author":"M Yi","year":"2020","unstructured":"Yi M, Zhou L, Li A, Luo S, Wu K. Global burden and trend of acute lymphoblastic leukemia from 1990 to 2017. Aging (Albany NY). 2020;12(22):22869\u201391.","journal-title":"Aging (Albany NY)"},{"key":"198_CR26","first-page":"1","volume":"1","author":"E Mohammadi","year":"2020","unstructured":"Mohammadi E, Aminorroaya A, Fattahi N, Azadnajafabad S, Rezaei N, Farzi Y, et al. Epidemiologic pattern of cancers in Iran; current knowledge and future perspective. J Diabetes Metab Disorders. 2020;1:1\u20135.","journal-title":"J Diabetes Metab Disorders."},{"key":"198_CR27","first-page":"1","volume":"1","author":"A Aminorroaya","year":"2020","unstructured":"Aminorroaya A, Fattahi N, Azadnajafabad S, Mohammadi E, Jamshidi K, Khalilabad MR, et al. Burden of non-communicable diseases in Iran: past, present, and future. J Diabetes Metab Disorders. 2020;1:1\u20137.","journal-title":"J Diabetes Metab Disorders."},{"issue":"1","key":"198_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"198_CR29","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1016\/S2352-3026(17)30232-6","volume":"5","author":"A Miranda-Filho","year":"2018","unstructured":"Miranda-Filho A, Pi\u00f1eros M, Ferlay J, Soerjomataram I, Monnereau A, Bray F. Epidemiological patterns of leukaemia in 184 countries: a population-based study. Lancet Haematol. 2018;5(1):e14\u201324.","journal-title":"Lancet Haematol"},{"issue":"100","key":"198_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.socscimed.2014.06.030","volume":"116","author":"S Brown","year":"2014","unstructured":"Brown S, Castelli M, Hunter DJ, Erskine J, Vedsted P, Foot C, et al. How might healthcare systems influence speed of cancer diagnosis: a narrative review. Soc Sci Med. 2014;116(100):56\u201363.","journal-title":"Soc Sci Med"},{"key":"198_CR31","unstructured":"Global Health and Aging: World Health Organization; [updated November 1, 2020. https:\/\/www.who.int\/ageing\/publications\/global_health.pdf."},{"issue":"10","key":"198_CR32","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/cncr.28614","volume":"120","author":"D Hui","year":"2014","unstructured":"Hui D, Didwaniya N, Vidal M, Shin SH, Chisholm G, Roquemore J, et al. Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer. 2014;120(10):1572\u20138.","journal-title":"Cancer"},{"issue":"1","key":"198_CR33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/00981380903018470","volume":"49","author":"MA Burg","year":"2010","unstructured":"Burg MA, Zebrack B, Walsh K, Maramaldi P, Lim JW, Smolinski KM, et al. Barriers to accessing quality health care for cancer patients: a survey of members of the association of oncology social work. Soc Work Health Care. 2010;49(1):38\u201352.","journal-title":"Soc Work Health Care"},{"key":"198_CR34","unstructured":"ESMO Clinical Practice Guidelines: Haematological Malignancies: European Society for Medical Oncology (ESMO) [updated November 1, 2020. https:\/\/www.esmo.org\/guidelines\/haematological-malignancies."},{"issue":"3","key":"198_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.21147\/j.issn.1000-9604.2017.03.11","volume":"29","author":"Y Cai","year":"2017","unstructured":"Cai Y, Xue M, Chen W, Hu M, Miao Z, Lan L, et al. Expenditure of hospital care on cancer in China, from 2011 to 2015. Chin J Cancer Res. 2017;29(3):253\u201362.","journal-title":"Chin J Cancer Res"},{"issue":"5","key":"198_CR36","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","volume":"6","author":"H Zeng","year":"2018","unstructured":"Zeng H, Chen W, Zheng R, Zhang S, Ji JS, Zou X, et al. Changing cancer survival in China during 2003\u201315: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018;6(5):e555\u201367.","journal-title":"Lancet Glob Health"},{"issue":"4","key":"198_CR37","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/0284186X.2017.1407039","volume":"57","author":"E Pukkala","year":"2018","unstructured":"Pukkala E, Engholm G, H\u00f8jsgaard Schmidt LK, Storm H, Khan S, Lambe M, et al. Nordic Cancer Registries - an overview of their procedures and data comparability. Acta Oncol. 2018;57(4):440\u201355.","journal-title":"Acta Oncol"},{"key":"198_CR38","unstructured":"National Blood Cancer Registry: Austrakazian Leukemia & Lymphoma Group; [updated November 1, 2020. https:\/\/www.allg.org.au\/clinical-trials-research\/national-blood-cancer-registry\/."},{"issue":"2","key":"198_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/1757975914537094","volume":"22","author":"DS Busolo","year":"2015","unstructured":"Busolo DS, Woodgate RL. Cancer prevention in Africa: a review of the literature. Glob Health Promot. 2015;22(2):31\u20139.","journal-title":"Glob Health Promot"},{"issue":"22","key":"198_CR40","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1182\/blood-2012-02-387092","volume":"119","author":"S Gopal","year":"2012","unstructured":"Gopal S, Wood WA, Lee SJ, Shea TC, Naresh KN, Kazembe PN, et al. Meeting the challenge of hematologic malignancies in sub-Saharan Africa. Blood. 2012;119(22):5078\u201387.","journal-title":"Blood"},{"key":"198_CR41","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2147\/IJGM.S223882","volume":"12","author":"OO Oleribe","year":"2019","unstructured":"Oleribe OO, Momoh J, Uzochukwu BS, Mbofana F, Adebiyi A, Barbera T, et al. Identifying Key Challenges Facing Healthcare Systems In Africa And Potential Solutions. Int J Gen Med. 2019;12:395\u2013403.","journal-title":"Int J Gen Med"},{"issue":"5","key":"198_CR42","doi-asserted-by":"publisher","first-page":"e0232848","DOI":"10.1371\/journal.pone.0232848","volume":"15","author":"SA Leak","year":"2020","unstructured":"Leak SA, Mmbaga LG, Mkwizu EW, Mapendo PJ, Henke O. Hematological malignancies in East Africa-Which cancers to expect and how to provide services. PLoS ONE. 2020;15(5):e0232848.","journal-title":"PLoS ONE"},{"issue":"6","key":"198_CR43","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/j.1365-2141.2011.08772.x","volume":"154","author":"KN Naresh","year":"2011","unstructured":"Naresh KN, Raphael M, Ayers L, Hurwitz N, Calbi V, Rogena E, et al. Lymphomas in sub-Saharan Africa\u2013what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research? Br J Haematol. 2011;154(6):696\u2013703.","journal-title":"Br J Haematol"},{"issue":"1","key":"198_CR44","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1200\/JGO.2015.000406","volume":"1","author":"DC Stefan","year":"2015","unstructured":"Stefan DC. Cancer Care in Africa: An Overview of Resources. J Glob Oncol. 2015;1(1):30\u20136.","journal-title":"J Glob Oncol"},{"key":"198_CR45","first-page":"18","volume":"25","author":"NP Martial","year":"2016","unstructured":"Martial NP, Sieleunou I. An appeal for large scale production of antiretroviral drugs in Africa. Pan Afr Med J. 2016;25:18.","journal-title":"Pan Afr Med J"},{"issue":"14","key":"198_CR46","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1056\/NEJMp1410433","volume":"373","author":"R Atun","year":"2015","unstructured":"Atun R. Transforming Turkey\u2019s Health System-Lessons for Universal Coverage. N Engl J Med. 2015;373(14):1285\u20139.","journal-title":"N Engl J Med"},{"issue":"9","key":"198_CR47","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.healthpol.2015.07.008","volume":"119","author":"H Yu","year":"2015","unstructured":"Yu H. Universal health insurance coverage for 1.3 billion people: What accounts for China\u2019s success? Health Policy. 2015;119(9):1145\u201352.","journal-title":"Health Policy"},{"issue":"1","key":"198_CR48","doi-asserted-by":"publisher","first-page":"e0190298","DOI":"10.1371\/journal.pone.0190298","volume":"13","author":"KJ Joling","year":"2018","unstructured":"Joling KJ, van Eenoo L, Vetrano DL, Smaardijk VR, Declercq A, Onder G, et al. Quality indicators for community care for older people: a systematic review. PLoS ONE. 2018;13(1):e0190298.","journal-title":"PLoS ONE"},{"issue":"16","key":"198_CR49","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1001\/jama.2016.12335","volume":"316","author":"JW Rowe","year":"2016","unstructured":"Rowe JW, Fulmer T, Fried L. Preparing for better health and health care for an aging population. JAMA. 2016;316(16):1643\u20134.","journal-title":"JAMA"},{"issue":"2","key":"198_CR50","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.critrevonc.2008.01.013","volume":"67","author":"JF Piccirillo","year":"2008","unstructured":"Piccirillo JF, Vlahiotis A, Barrett LB, Flood KL, Spitznagel EL, Steyerberg EW. The changing prevalence of comorbidity across the age spectrum. Crit Rev Oncol Hematol. 2008;67(2):124\u201332.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2\u20133","key":"198_CR51","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.mrrev.2006.09.001","volume":"613","author":"AS Kim","year":"2006","unstructured":"Kim AS, Eastmond DA, Preston RJ. Childhood acute lymphocytic leukemia and perspectives on risk assessment of early-life stage exposures. Mutat Res. 2006;613(2\u20133):138\u201360.","journal-title":"Mutat Res"},{"issue":"1","key":"198_CR52","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1007\/s00259-003-1154-9","volume":"30","author":"A Swerdlow","year":"2003","unstructured":"Swerdlow A. Epidemiology of Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma. Eur J Nucl Med Mol Imaging. 2003;30(1):S3\u201312.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"198_CR53","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1751-486X.2012.01761.x","volume":"16","author":"SK Cesario","year":"2012","unstructured":"Cesario SK. Global inequalities in the care of women with cancer. Nurs Womens Health. 2012;16(5):372\u201385.","journal-title":"Nurs Womens Health"},{"issue":"3","key":"198_CR54","doi-asserted-by":"publisher","first-page":"453","DOI":"10.21037\/jgo.2019.02.04","volume":"10","author":"D Laghousi","year":"2019","unstructured":"Laghousi D, Jafari E, Nikbakht H, Nasiri B, Shamshirgaran M, Aminisani N. Gender differences in health-related quality of life among patients with colorectal cancer. J Gastrointest Oncol. 2019;10(3):453\u201361.","journal-title":"J Gastrointest Oncol"},{"issue":"10","key":"198_CR55","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s10552-007-9061-1","volume":"18","author":"M Merhi","year":"2007","unstructured":"Merhi M, Raynal H, Cahuzac E, Vinson F, Cravedi JP, Gamet-Payrastre L. Occupational exposure to pesticides and risk of hematopoietic cancers: meta-analysis of case-control studies. Cancer Causes Control. 2007;18(10):1209\u201326.","journal-title":"Cancer Causes Control"},{"issue":"21","key":"198_CR56","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/jnci\/djg083","volume":"95","author":"M Hauptmann","year":"2003","unstructured":"Hauptmann M, Lubin JH, Stewart PA, Hayes RB, Blair A. Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries. J Natl Cancer Inst. 2003;95(21):1615\u201323.","journal-title":"J Natl Cancer Inst"},{"key":"198_CR57","unstructured":"GBD 2017 HIV collaborators. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980\u20132017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Lancet HIV. 2019;6(12):e831-e59."},{"issue":"2","key":"198_CR58","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/ijc.25903","volume":"129","author":"E Lanoy","year":"2011","unstructured":"Lanoy E, Spano JP, Bonnet F, Guiguet M, Bou\u00e9 F, Cadranel J, et al. The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH study. Int J Cancer. 2011;129(2):467\u201375.","journal-title":"Int J Cancer"},{"issue":"7","key":"198_CR59","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s10552-008-9134-9","volume":"19","author":"DJ Lee","year":"2008","unstructured":"Lee DJ, Voti L, MacKinnon J, Koniaris LG, Fleming LE, Huang Y, et al. Gender- and race-specific comparison of tobacco-associated cancer incidence trends in Florida with SEER regional cancer incidence data. Cancer Causes Control. 2008;19(7):711\u201323.","journal-title":"Cancer Causes Control"},{"issue":"3","key":"198_CR60","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.leukres.2006.07.002","volume":"31","author":"G Gorini","year":"2007","unstructured":"Gorini G, Stagnaro E, Fontana V, Miligi L, Ramazzotti V, Nanni O, et al. Alcohol consumption and risk of leukemia: a multicenter case-control study. Leuk Res. 2007;31(3):379\u201386.","journal-title":"Leuk Res"}],"container-title":["Experimental Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-021-00198-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40164-021-00198-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-021-00198-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T22:51:41Z","timestamp":1612824701000},"score":1,"resource":{"primary":{"URL":"https:\/\/ehoonline.biomedcentral.com\/articles\/10.1186\/s40164-021-00198-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,8]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["198"],"URL":"https:\/\/doi.org\/10.1186\/s40164-021-00198-2","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,8]]},"assertion":[{"value":"28 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}